...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

All the Pharma boys looking thru BET window for certain now . Is this data as good as it appears ? More importantly tox profile looks best in class as well.

 

Share
New Message
Please login to post a reply